Related Experiment Video
Updated: Jul 9, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Saudi Heart Association Position Statement on Adult Vaccinations for Patients With Cardiovascular Diseases
Waleed Alhabeeb1, Fayssal M Farahat2, Majid M Alshamrani2
1Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
Insights
Adults with cardiovascular diseases (CVD) should receive recommended vaccines to prevent serious infections. The Saudi Heart Association (SHA) developed guidelines for integrating adult immunization into cardiovascular care, improving patient outcomes.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- Cardiovascular diseases (CVD) are a leading global cause of death.
- Patients with CVD face higher risks from vaccine-preventable infections.
- Adult vaccination rates remain suboptimal, particularly among those with CVD.
Purpose of the Study:
- To establish evidence-based recommendations for adult immunization in patients with cardiovascular disease (CVD).
- To guide the Saudi Heart Association (SHA) in promoting vaccination for CVD patients.
Main Methods:
- A multidisciplinary expert panel convened by the SHA.
- Comprehensive literature review of randomized trials, observational studies, and real-world data.
- Series of consensus meetings to formulate recommendations.
Main Results:
- Vaccines significantly reduce the risk of major adverse cardiovascular events in individuals with CVD.
- Evidence supports vaccinations against influenza, COVID-19, RSV, herpes zoster, pneumococcal, and meningococcal diseases.
- Vaccination is a crucial component of comprehensive cardiovascular care.
Conclusions:
- The SHA recommends routine vaccination for all adult patients with CVD.
- Integration of vaccine assessment and administration into cardiology practice is essential.
- Healthcare provider engagement, patient education, and targeted outreach (e.g., during Hajj/Umrah) are key strategies.
Background:
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide. Individuals with CVD are particularly vulnerable to severe complications from vaccine-preventable infections; however, adult vaccination continues to be underutilized.
Methods:
A multidisciplinary expert panel from the Saudi Heart Association (SHA) conducted a comprehensive literature review and a series of consensus meetings to develop evidence-based recommendations for adult immunization in patients with CVD.
Results And Conclusions:
Evidence from randomized trials, observational studies, and real-world data supports the role of vaccines in reducing the risk of major adverse cardiovascular events in individuals with CVD. The SHA recommends the implementation of age-appropriate vaccinations against influenza, COVID-19, respiratory syncytial virus (RSV), herpes zoster, pneumococcal disease and meningococcal disease as an integral component of cardiovascular care. Recommendations emphasize routine vaccine assessment, integration into cardiology practice, healthcare provider engagement, patient education, and leveraging high-risk periods such as Hajj and Umrah for vaccination outreach.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures

